Results 41 to 50 of about 12,912 (170)
Circulating Differentially Methylated Amylin DNA as a Biomarker of β-Cell Loss in Type 1 Diabetes. [PDF]
In type 1 diabetes (T1D), β-cell loss is silent during disease progression. Methylation-sensitive quantitative real-time PCR (qPCR) of β-cell-derived DNA in the blood can serve as a biomarker of β-cell death in T1D.
John A Olsen +4 more
doaj +1 more source
Rutin inhibits amylin-induced neurocytotoxicity and oxidative stress
Recent evidence showed that amylin deposition is not only found in the pancreas in type 2 diabetes mellitus (T2DM) patients, but also in other peripheral organs, such as kidneys, heart and brain.
Yu, Xiao-Lin +9 more
core +1 more source
(A) Single layer conformation of human amylin, (B) single layer conformation of rat amylin, (C) single layer conformation of human-rat complex, (D) Double layer conformation of human amylin with CC interface (E) Double layer conformation of rat amylin ...
Workalemahu M. Berhanu (314489) +1 more
core +1 more source
Background: After glucagon and insulin, amylin is the third most significant and active islet hormone. Amylin and insulin act synergistically to suppress postprandial blood glucose levels.
Li Liu, Wenxuan Liu, Wenhong Deng
doaj +1 more source
Amylin is a peptide hormone that is mainly known to be produced by pancreatic β-cells in response to a meal but amylin is also produced by brain cells in discrete brain areas albeit in a lesser amount. Amylin receptor (AMY) is composed of the calcitonin core-receptor (CTR) and one of the 3 receptor activity modifying protein (RAMP), thus forming AMY1-3;
Boccia, Lavinia +5 more
openaire +3 more sources
The development of inhibitors of islet amyloid formation is important as pancreatic amyloid deposition contributes to type-2 diabetes and islet transplant failure.
Rehana Akter +4 more
doaj +1 more source
Associations of amylin with inflammatory markers and metabolic syndrome in apparently healthy Chinese. [PDF]
BACKGROUND: Cellular and animal studies implicate multiple roles of amylin in regulating insulin action, glucose and lipid metabolisms. However, the role of amylin in obesity related metabolic disorders has not been thoroughly investigated in humans ...
Xinwei Hou +11 more
doaj +1 more source
Amylin as a Future Obesity Treatment
Obesity is defined as abnormal or excessive fat accumulation that contributes to detrimental health impacts. One-third of the population suffers from obesity, and it is important to consider obesity as a chronic disease requiring chronic treatment ...
Babak Dehestani +2 more
doaj +1 more source
Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide
Full-length native rat amylin 1-37 has previously been widely shown to be unable to form fibrils and to lack the toxicity of the human amylin form leading to its use as a non-amyloidogenic control peptide.
Harris, J.R., Milton, N.G.N.
core +1 more source
Biotinyl analogues of amylin as biologically active probes for amylin/CGRP receptor recognition
Biotinyl analogues of rat amylin were synthesised with sulfosuccinimidyl 2-(biotinamido)ethyl-1,3-dithiopropionate(NHS-SS-Biotin). Biotinylated amylin peptides were purified by HPLC, quantitated, and the presence of the biotin group at Lys-1 confirmed by
Foot, Elizabeth A. +9 more
core +1 more source

